Glucocorticoid-induced osteoporosis prevention in polymyalgia rheumatica patients

Simple item page
dc.contributor.authorSwami, Tara
dc.contributor.authorMolloy, C.
dc.date.accessioned2021-09-21T13:17:27Z
dc.date.available2021-09-21T13:17:27Z
dc.date.issued2020
dc.description.abstractAim: Studies indicate that <50% of polymyalgia rheumatica (PMR) patients receive bone protective therapy (BPT) for glucocorticoid-induced osteoporosis (GIOP) prevention. We sought to determine if PMR patients are protected from GIOP by examining bone densitometry (DXA) scan results, BPT use, and adherence to guidelines. Methods: PMR patients treated with glucocorticoids who underwent a DXA scan at Cork University Hospital from 01/01/2016 to 27/10/2017 were included. Patient data were obtained from chart review. Results: Out of 153 patients, 73 (47.7%) were taking BPT and 42 (27.5%) were not. At the most recent DXA scan, 42 (27.5%) had normal BMD, 84 (54.9%) were osteopaenic, and 27 (17.6%) were osteoporotic. In 91 individuals who underwent≥2 DXA scans, patients not receiving bisphosphonates were more likely to have BMD loss over time (p=0.022). Discussion: Despite recommendations, many patients are not prescribed BPT. The results suggest that PMR patients in Cork are not optimally protected from GIOP.en
dc.description.statusPeer revieweden
dc.description.versionPublished Versionen
dc.format.mimetypeapplication/pdfen
dc.identifier.articleidP36en
dc.identifier.citationSwami, T. and Molloy, C. (2020) 'Glucocorticoid-induced osteoporosis prevention in polymyalgia rheumatica patients' Irish Medical Journal, 113(3), P36 (7pp). Available at: http://www.imj.ie/wp-content/uploads/2020/03/Glucocorticoid-Induced-Osteoporosis-Prevention-in-Polymyalgia-Rheumatica-Patients.pdf (Accessed: 21 September 2021)en
dc.identifier.endpage7en
dc.identifier.issn0332-3102
dc.identifier.issued3en
dc.identifier.journaltitleIrish Medical Journalen
dc.identifier.startpage1en
dc.identifier.urihttps://hdl.handle.net/10468/11973
dc.identifier.volume113en
dc.language.isoenen
dc.publisherIrish Medical Organisationen
dc.relation.urihttps://imj.ie/irish-medical-journal-March-2020-vol-113-no-3/
dc.rights© 2020, Irish Medical Journal. All rights reserved.en
dc.subjectPolymyalgia rheumaticaen
dc.subjectPMRen
dc.subjectBone protective therapyen
dc.subjectBPTen
dc.subjectGlucocorticoid-induced osteoporosisen
dc.subjectGIOPen
dc.titleGlucocorticoid-induced osteoporosis prevention in polymyalgia rheumatica patientsen
dc.typeArticle (peer-reviewed)en
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Glucocorticoid-Induced-Osteoporosis-Prevention-in-Polymyalgia-Rheumatica-Patients.pdf
Size:
571.22 KB
Format:
Adobe Portable Document Format
Description:
Published Version
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
2.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Medicine - Journal Articles